0001104659-26-043786
SEC filingRevenue reached $529.7M with gross profit of $41.2M at 7.8% margin, reflecting improved cost dynamics, but operating loss of -$112.2M and net loss of -$210.3M persisted amid high expenses and financing charges.
Despite gross margin recovery, operating income landed at a loss of -$112.2 million, or -21.2% of revenue. This reflects elevated operating expenses necessary to sustain R&D and production amid supply chain challenges. Canaan maintains multiple production partners to mitigate chip shortages and supplier risks, but prepayments to secure capacity create working capital strain, contributing to the operating shortfall. Management notes disciplined cost controls in areas like staff and share-based compensation, though new product development requires ongoing investment.
Cash flow from operations consumed -$271.2 million, driven by outflows for inventory and prepayments inherent to early-stage production processes. Adding $24.6 million in capital expenditures for capacity expansion, free cash flow reached -$295.8 million. This burn highlights liquidity pressures, prompting management to consider additional equity or debt financing to bolster reserves for future investments, acquisitions, or growth opportunities. Canaan continues capital expenditures to meet expected business expansion, while cautioning that past results do not predict future performance given market dynamics.